Bile Acids Activated Receptors in Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Once known exclusively for their role in nutrients absorption, bile acids have emerged as signaling molecules, generated from cholesterol breakdown, acting on several immune cells by activating a variety of receptors including the G protein-coupled bile acid receptor 1 (GPABR1 or TGR5), the Farnesoid-X-receptor (FXR) and, as recently discovered, the retinoid-related orphan receptors (ROR)γt. GPBAR1, FXR, and RORγt are highly expressed in cells of the innate and adaptive immune system (i.e., dendritic cells (DCs), macrophages, innate lymphoid 3 cells (ILC3s), and T helper 17 (Th17) lymphocytes) and plays an important role in regulating intestinal and liver immunity, highlighting a role for various bile acid species in regulating immune responses to intestinal microbial antigens. While primary bile acids are generated from the cholesterol breakdown secondary bile acids, the GPBAR1 ligands, and oxo-bile acids derivatives, the RORγt ligands, are generated by the intestinal microbiota, highlighting the potential of these bile acids in mediating the chemical communication between the intestinal microbiota and the host. Changes in intestinal microbiota, dysbiosis, alter the composition of the bile acid pool, promoting the activation of the immune system and development of chronic inflammation. In this review, we focus on the molecular mechanisms by which an altered bile acid signaling promotes intestinal inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“BA metabolism is defective in patients with IBD, as indicated by increased levels of primary BAs (PBAs) and/or their conjugated forms, accompanied by decreased levels of second BAs (SBAs) (Lavelle and Sokol, 2020; Biagioli et al., 2021; Gallagher et al., 2021).”
From Bacteroides dorei BDX-01 alleviates DSS-induced experimental colitis in mice by regulating intestinal bile salt hydrolase activity and the FXR-NLRP3 signaling pathway (2023) · cites this paper as Biagioli et al., 2021
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S. J., Yassour, M., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.005 · Cited by 3,220
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1237-9 · Cited by 3,143
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069 · cited 1×
“The large majority of these deconjugated primary bile acids and secondary bile acids that reach the terminal ileum are reabsorbed by the intestinal epithelial cells (IEC) and transported back to the liver through the portal vein, completing a cycle in the “enterohepatic circulation” [11,20,21].”
BackgroundGut microbiota-derived metabolites as key actors in inflammatory bowel disease
Lavelle, A., & Sokol, H. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0258-z · Cited by 2,015
Gut microbiome structure and metabolic activity in inflammatory bowel disease
Franzosa, E. A., Sirota-Madi, A., Avila-Pacheco, J., Fornelos, N., Haiser, H. J., Reinker, S., Vatanen, T., Hall, A. B., Mallick, H., McIver, L. J., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0306-4 · Cited by 1,995 · cited 2×
“[81] demonstrated that patients with active IBD have a reduction in the fecal content of DCA and LCA (secondary bile acids) associated with a sharp increase in the content of primary bile acids.”
BackgroundEndogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Immunopathogenesis of IBD: current state of the art
de Souza, H. S. P., & Fiocchi, C. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.186 · Cited by 1,551
Bile acids: regulation of synthesis
Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,515 · cited 1×
“The large majority of these deconjugated primary bile acids and secondary bile acids that reach the terminal ileum are reabsorbed by the intestinal epithelial cells (IEC) and transported back to the liver through the portal vein, completing a cycle in the “enterohepatic circulation” [11,20,21].”
BackgroundGut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
Ma, C., Han, M., Heinrich, B., Fu, Q., Zhang, Q., Sandhu, M., Agdashian, D., Terabe, M., Berzofsky, J. A., Fako, V., et al. (2018) · Science · doi:10.1126/science.aan5931 · Cited by 1,508 · cited 1×
“In this study, we have shown that obeticholic acid (INT-747) inhibited the influx of NKT cells and the ability of these cells to produce osteopontin in rodent models of acute hepatitis [42,56,57].”
BackgroundMoayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
Bile acid metabolites control TH17 and Treg cell differentiation
Hang, S., Paik, D., Yao, L., Kim, E., Trinath, J., Lu, J., Ha, S., Nelson, B. N., Kelly, S. P., Wu, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1785-z · Cited by 1,457
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379 · cited 1×
“As for nuclear receptors, bile acids also activate the constitutive androstane receptor (CAR, also known as NR1H3) [32], the pregnane-x-receptor (PXR, also known as NR1H2) [33], activated by CDCA, LCA, and DCA, and the vitamin D receptor (VDR, also known as NR1H1), activated by LCA and DCA [34].”
BackgroundDisease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease
Norman, J. M., Handley, S. A., Baldridge, M. T., Droit, L., Liu, C. Y., Keller, B. C., Kambal, A., Monaco, C. L., Zhao, G., Fleshner, P., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.002 · Cited by 1,285
Paramsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30182-4 · Cited by 1,276
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis
Song, X., Sun, X., Oh, S. F., Wu, M., Zhang, Y., Zheng, W., Geva-Zatorsky, N., Jupp, R., Mathis, D., Benoist, C., et al. (2020) · Nature · doi:10.1038/s41586-019-1865-0 · Cited by 1,024
Identification of membrane-type receptor for bile acids (M-BAR)
Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993
Eberl, G., Marmon, S., Sunshine, M.-J., Rennert, P. D., Choi, Y., & Littman, D. R. (2004) · Nature Immunology · doi:10.1038/ni1022 · Cited by 985
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935 · cited 1×
“The alternative pathway generates only CDCA and contributes 10% of total bile acid pool generated in the liver [13,14].”
BackgroundConnecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
Duboc, H., Rajca, S., Rainteau, D., Benarous, D., Maubert, M.-A., Quervain, E., Thomas, G., Barbu, V., Humbert, L., Despras, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302578 · Cited by 930 · cited 1×
“In addition, an increase in 3-OH-sulfate bile acid was observed in patients with active IBD [80].”
BackgroundRossen, N. G., Fuentes, S., van der Spek, M. J., Tijssen, J. G., Hartman, J. H. A., Duflou, A., Löwenberg, M., van den Brink, G. R., Mathus-Vliegen, E. M. H., de Vos, W. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.045 · Cited by 921
Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats
Islam, K. B. M. S., Fukiya, S., Hagio, M., Fujii, N., Ishizuka, S., Ooka, T., Ogura, Y., Hayashi, T., & Yokota, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.046 · Cited by 918 · cited 1×
“At the basal state, the NCor1 complex is bound on the promoter of these genes, preventing the binding of NF-kB and keeping them in a state of transcriptional inactivity [41].”
BackgroundGadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut · doi:10.1136/gut.2010.212159 · Cited by 870 · cited 9×
“Gadaleta et al. showed that OCA significantly decreased the severity of DSS- and TNBS [54,99] e.”
BackgroundInfluentialPellicciari, R., Fiorucci, S., Camaioni, E., Clerici, C., Costantino, G., Maloney, P. R., Morelli, A., Parks, D. J., & Willson, T. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025529g · Cited by 743
Self-citationLi, F., Jiang, C., Krausz, K. W., Li, Y., Albert, I., Hao, H., Fabre, K. M., Mitchell, J. B., Patterson, A. D., & Gonzalez, F. J. (2013) · Nature Communications · doi:10.1038/ncomms3384 · Cited by 705 · cited 1×
“Moreover, 6α/βMCA bile acid, the two main bile acids found in mice in addition to TCA, acts as an FXR antagonist [28,29].”
BackgroundJetten, A. M. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07003 · Cited by 673
The bile acid receptor FXR is a modulator of intestinal innate immunity
Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803978 · Cited by 655 · cited 10×
“The activation of toll like receptor-4 (TLR-4) causes the release of NCor1 from the promoters, allowing the transcriptional activation of these genes [39].”
BackgroundSelf-citationGlobal chemical effects of the microbiome include new bile-acid conjugations
Quinn, R. A., Melnik, A. V., Vrbanac, A., Fu, T., Patras, K. A., Christy, M. P., Bodai, Z., Belda-Ferre, P., Tripathi, A., Chung, L. K., et al. (2020) · Nature · doi:10.1038/s41586-020-2047-9 · Cited by 579 · cited 2×
“Recently, new microbiome-conjugated bile acids with tyrosine, phenylalanine, and leucine have also been identified, which give rise respectively to tyrosocholic acid, phenylalanocholic acid, and leucocholic acid [19].”
BackgroundImmunological pathogenesis of inflammatory bowel disease
Lee, S. H., Kwon, J. E., & Cho, M.-L. (2018) · Intestinal Research · doi:10.5217/ir.2018.16.1.26 · Cited by 575
Bile Acids Activated Receptors Regulate Innate Immunity
Fiorucci, S., Biagioli, M., Zampella, A., & Distrutti, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01853 · Cited by 562 · cited 2×
“However, bile acids are also signaling molecules regulating a number of physiologically relevant processes by activating a group of G-protein-coupled and nuclear receptors collectively known as “Bile acid-activated receptor “(BARs) [1,2].”
BackgroundSelf-citationIntestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
Jiang, C., Xie, C., Lv, Y., Li, J., Krausz, K. W., Shi, J., Brocker, C. N., Desai, D., Amin, S. G., Bisson, W. H., et al. (2015) · Nature Communications · doi:10.1038/ncomms10166 · Cited by 559 · cited 1×
“Moreover, 6α/βMCA bile acid, the two main bile acids found in mice in addition to TCA, acts as an FXR antagonist [28,29].”
BackgroundRivollier, A., He, J., Kole, A., Valatas, V., & Kelsall, B. L. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20101387 · Cited by 549 · cited 1×
“Importantly, although BAR501 effectively reduced the number of circulating monocytes, it failed to alter the ratio of Ly6C+/Ly6C2 cells, confirming that Ly6C expression per se does not affect the differentiation of monocytes toward a pro- or anti-inflammatory phenotype and that the differentiation of Ly6C+ monocytes,…”
BackgroundBile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders
Fiorucci, S., & Distrutti, E. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.09.001 · Cited by 539 · cited 2×
“BARs widely expressed receptors and are found in different cells of the gastrointestinal tract: intestinal epithelial cells (FXR and GPBAR1), intestinal muscle and neurons (GPBAR1), biliary cells (FXR and GPBAR1), hepatocytes (FXR), liver sinusoidal cells (FXR and GPBAR1), and liver and intestinal endothelial cells (F…”
BackgroundSelf-citationBacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease
Hoarau, G., Mukherjee, P. K., Gower-Rousseau, C., Hager, C., Chandra, J., Retuerto, M. A., Neut, C., Vermeire, S., Clemente, J., Colombel, J. F., et al. (2016) · mBio · doi:10.1128/mbio.01250-16 · Cited by 480
Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis
Hao, H., Cao, L., Jiang, C., Che, Y., Zhang, S., Takahashi, S., Wang, G., & Gonzalez, F. J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.007 · Cited by 469 · cited 3×
“Like FXR, GPBAR1 also exerts a counter-regulatory effects on the activation of the NLPR3 inflammasome [50,53].”
BackgroundCipriani, S., Mencarelli, A., Chini, M. G., Distrutti, E., Renga, B., Bifulco, G., Baldelli, F., Donini, A., & Fiorucci, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025637 · Cited by 382 · cited 3×
“In vivo studies have shown that ablation of the Gpbar1 gene in mice results in a phenotype characterized by molecular alterations of the structure of tight junctions between intestinal epithelial cells with an increase in expression and an abnormal subcellular distribution of zonulin 1, leading to an increased intesti…”
BackgroundSelf-citationMoore, L. B., Maglich, J. M., McKee, D. D., Wisely, B., Willson, T. M., Kliewer, S. A., Lambert, M. H., & Moore, J. T. (2002) · Molecular Endocrinology · doi:10.1210/me.16.5.977 · Cited by 355 · cited 2×
“Moreover, hyodeoxycholic acid (HDCA or Hyo-DCA), present in high concentrations in patients with cholestasis, activates the liver-X-receptor α and β (LXRα/β, NR1H3) [35].”
BackgroundWestergaard, H., & Dietschy, J. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108465 · Cited by 342 · cited 1×
“This amphipathic structure gives them detergent properties that are essential for solubilizing lipids in the micelles, facilitating emulsification and absorption of dietary lipids and fat-soluble vitamins [8].”
BackgroundBiagioli, M., Carino, A., Cipriani, S., Francisci, D., Marchianò, S., Scarpelli, P., Sorcini, D., Zampella, A., & Fiorucci, S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700183 · Cited by 327 · cited 13×
“NKT cells express both FXR and GPBAR1 but the role of activating also GPBAR1 in these cells has been investigated only in the liver.”
BackgroundSelf-citationTargeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice
Maruyama, T., Tanaka, K., Suzuki, J., Miyoshi, H., Harada, N., Nakamura, T., Miyamoto, Y., Kanatani, A., & Tamai, Y. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06546 · Cited by 288 · cited 1×
“Moreover, other innate immune cells such as DCs and NKT cells express the receptor [40,58,59].”
BackgroundBile Acid Metabolism and Signaling
Chiang, J. Y. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00517.x · Cited by 279 · cited 2×
“Indeed, in contrast to humans, mice only generate CA from cholesterol, since CDCA in the rodent liver is transformed into α- and β-muricholic acid (MCA) by the enzyme CYP2C70 present only in mice and not in humans [9,17].”
BackgroundBile acids and their receptors in metabolic disorders
Fiorucci, S., Distrutti, E., Carino, A., Zampella, A., & Biagioli, M. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101094 · Cited by 258 · cited 3×
“BARs widely expressed receptors and are found in different cells of the gastrointestinal tract: intestinal epithelial cells (FXR and GPBAR1), intestinal muscle and neurons (GPBAR1), biliary cells (FXR and GPBAR1), hepatocytes (FXR), liver sinusoidal cells (FXR and GPBAR1), and liver and intestinal endothelial cells (F…”
BackgroundSelf-citationLochner, M., Ohnmacht, C., Presley, L., Bruhns, P., Si-Tahar, M., Sawa, S., & Eberl, G. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100052 · Cited by 254 · cited 7×
“(C,D) Recently, it was shown that oxo-bile acid derivatives, specifically the 3-oxo-LCA, can bind RORγt by acting as an inverse agonist, decreasing the production of IL-17 in T helper cells and ILCs by reducing the polarization towards the Th17 and ILC3 subtypes.”
BackgroundInfluentialWithers, D. R., Hepworth, M. R., Wang, X., Mackley, E. C., Halford, E. E., Dutton, E. E., Marriott, C. L., Brucklacher-Waldert, V., Veldhoen, M., Kelsen, J., et al. (2016) · Nature Medicine · doi:10.1038/nm.4046 · Cited by 243 · cited 1×
“Both groups demonstrated that binding of RORγt to 3-oxo-LCA decreased IL-17 production and Th17 cell numbers by attenuating intestinal inflammation in a mouse model of colitis [72,73].”
BackgroundYoneno, K., Hisamatsu, T., Shimamura, K., Kamada, N., Ichikawa, R., Kitazume, M. T., Mori, M., Uo, M., Namikawa, Y., Matsuoka, K., et al. (2013) · Immunology · doi:10.1111/imm.12045 · Cited by 225 · cited 2×
“Activation of GPBAR1 in DCs attenuates the bias towards the pro-inflammatory phenotype that produces IL-12 and TNF-α by promoting the polarization towards a tolerogenic phenotype that produces low levels of IL-12 [59,61] (Figure 2).”
BackgroundBile Acid Signaling in Inflammatory Bowel Diseases
Fiorucci, S., Carino, A., Baldoni, M., Santucci, L., Costanzi, E., Graziosi, L., Distrutti, E., & Biagioli, M. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06715-3 · Cited by 224 · cited 4×
“Thanks to this dual activity, the activation of GPBAR1 shift colonic macrophages from M1 pro-inflammatory phenotype to a M2 anti-inflammatory phenotype, relieving colitis in mouse models of the disease [2,43].”
BackgroundSelf-citationNagahashi, M., Takabe, K., Liu, R., Peng, K., Wang, X., Wang, Y., Hait, N. C., Wang, X., Allegood, J. C., Yamada, A., et al. (2015) · Hepatology · doi:10.1002/hep.27592 · Cited by 211 · cited 1×
“Among the membrane receptors activated by bile acids, we find the sphingosine 1-phosphate receptor (S1PR2) [30], which binds LCA, the muscarinic receptor M2 and M3, activated by DCA and LCA, the formyl peptide receptors (FPR), of which CDCA is an antagonist [31], and vascular endothelial growth factor receptor (VEGF-R…”
BackgroundStructural Basis for Hydroxycholesterols as Natural Ligands of Orphan Nuclear Receptor RORγ
Jin, L., Martynowski, D., Zheng, S., Wada, T., Xie, W., & Li, Y. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0507 · Cited by 210 · cited 1×
“Although RORs are considered orphan nuclear receptors, various oxysterols, and in particular, the cholesterol precursor, the 25-hydroxycholesterol, activate RORγt [70].”
BackgroundTargeting farnesoid X receptor for liver and metabolic disorders
Fiorucci, S., Rizzo, G., Donini, A., Distrutti, E., & Santucci, L. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.06.001 · Cited by 196
Self-citationPellicciari, R., Costantino, G., Camaioni, E., Sadeghpour, B. M., Entrena, A., Willson, T. M., Fiorucci, S., Clerici, C., & Gioiello, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049904b · Cited by 194
Self-citationGadaleta, R. M., Oldenburg, B., Willemsen, E. C. L., Spit, M., Murzilli, S., Salvatore, L., Klomp, L. W. J., Siersema, P. D., van Erpecum, K. J., & van Mil, S. W. C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.005 · Cited by 192 · cited 9×
“Gadaleta et al. showed that OCA significantly decreased the severity of DSS- and TNBS [54,99] e.”
BackgroundInfluentialGroup 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice
Montaldo, E., Juelke, K., & Romagnani, C. (2015) · European Journal of Immunology · doi:10.1002/eji.201545598 · Cited by 190
The bile acid sensor FXR regulates insulin transcription and secretion
Renga, B., Mencarelli, A., Vavassori, P., Brancaleone, V., & Fiorucci, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.01.002 · Cited by 189 · cited 1×
“In these cells, FXR modulates the expression of multiple genes involved in inflammation through both SHP-dependent and independent mechanisms [42,46].”
BackgroundSelf-citationYuk, J.-M., Shin, D.-M., Lee, H.-M., Kim, J.-J., Kim, S.-W., Jin, H. S., Yang, C.-S., Park, K. A., Chanda, D., Kim, D.-K., et al. (2011) · Nature Immunology · doi:10.1038/ni.2064 · Cited by 188 · cited 1×
“In addition to these mechanisms, SHP has been shown to prevent NLRP3 formation [51,52] (Figure 2A).”
BackgroundRecent advances in understanding bile acid homeostasis
Chiang, J. Y. (2017) · F1000Research · doi:10.12688/f1000research.12449.1 · Cited by 181 · cited 1×
“In humans, the bile acid pool consists of CA (≈40%), CDCA (≈40%), DCA (≈20%), with a glycine over taurine conjugation ratio of 3–1 [2,15,16].”
BackgroundMencarelli, A., Renga, B., Migliorati, M., Cipriani, S., Distrutti, E., Santucci, L., & Fiorucci, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901347 · Cited by 177 · cited 3×
“On the contrary, in the presence of an agonist, such as obeticholic acid (OCA, also known as INT-747), FXR is recruited to the iNOS and IL-1β promoters and stabilizes the NCoR1 complexes on the promoters of these two genes, causing a trans-repression [42] (Figure 2A).”
BackgroundSelf-citationCook, D. N., Kang, H. S., & Jetten, A. M. (2015) · Nuclear Receptor Research · doi:10.11131/2015/101185 · Cited by 173
Inflammatory bowel disease related innate immunity and adaptive immunity.
Huang, Y., & Chen, Z. (2016) · Europe PMC (PubMed Central) · Cited by 173
Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
Guo, C., Xie, S., Chi, Z., Zhang, J., Liu, Y., Zhang, L., Zheng, M., Zhang, X., Xia, D., Ke, Y., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.009 · Cited by 173 · cited 4×
“Like FXR, GPBAR1 also exerts a counter-regulatory effects on the activation of the NLPR3 inflammasome [50,53].”
BackgroundInfluentialHaselow, K., Bode, J. G., Wammers, M., Ehlting, C., Keitel, V., Kleinebrecht, L., Schupp, A.-K., Häussinger, D., & Graf, D. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0812396 · Cited by 164 · cited 1×
“pCREB acts both as an inducer of the transcription of some anti-inflammatory genes such as IL-10 [43], and as an inhibitor of the transcription of pro-inflammatory genes such as IL-1β or TNF-α by reducing the activity of NF-kB on the promoter of these genes [60].”
BackgroundKida, T., Tsubosaka, Y., Hori, M., Ozaki, H., & Murata, T. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301565 · Cited by 164 · cited 1×
“The mechanisms that support these immune-modulatory activities of FXR in cells of innate immunity involve both NF-KBdependent and -independent pathways as discussed in previous paragraphs [39,55,99,100].”
BackgroundFecal transplantation for treatment of inflammatory bowel disease
Imdad, A., Nicholson, M. R., Tanner-Smith, E. E., Zackular, J. P., Gomez-Duarte, O. G., Beaulieu, D. B., & Acra, S. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012774.pub2 · Cited by 164
Ichikawa, R., Takayama, T., Yoneno, K., Kamada, N., Kitazume, M. T., Higuchi, H., Matsuoka, K., Watanabe, M., Itoh, H., Kanai, T., et al. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03554.x · Cited by 161 · cited 15×
“The attenuation of inflammation and immune dysfunction caused by BAR501 was supported by a shift in the polarization of colonic macrophages from a pro-inflammatory M1 phenotype (CD11b+Ly6C−CCR7+CD38+IL-6+), towards an antiinflammatory M2 phenotype (CD11b+Ly6C−CCR7−Egr2+IL-10+).”
BackgroundResultInfluentialFecal transplantation for treatment of inflammatory bowel disease
Imdad, A., Nicholson, M. R., Tanner-Smith, E. E., Zackular, J. P., Gomez-Duarte, O., Borromeo Beaulieu, D. M., & Acra, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012774 · Cited by 158
Bile Acid-Activated Receptors: A Review on FXR and Other Nuclear Receptors
Shin, D., & Wang, L. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_236 · Cited by 149 · cited 1×
“SHP does not have the DNA binding domain and therefore exerts its activity through protein–protein interactions by acting as a co-repressor, facilitating the recruitment of other co-repressors on the promoter of FXR target genes [48].”
Backgroundde Boer, J. F., Verkade, E., Mulder, N. L., de Vries, H. D., Huijkman, N., Koehorst, M., Boer, T., Wolters, J. C., Bloks, V. W., van de Sluis, B., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000243 · Cited by 144 · cited 1×
“Indeed, in contrast to humans, mice only generate CA from cholesterol, since CDCA in the rodent liver is transformed into α- and β-muricholic acid (MCA) by the enzyme CYP2C70 present only in mice and not in humans [9,17].”
BackgroundYang, C.-S., Kim, J.-J., Kim, T. S., Lee, P. Y., Kim, S. Y., Lee, H.-M., Shin, D.-M., Nguyen, L. T., Lee, M.-S., Jin, H. S., et al. (2015) · Nature Communications · doi:10.1038/ncomms7115 · Cited by 140 · cited 1×
“In addition to these mechanisms, SHP has been shown to prevent NLRP3 formation [51,52] (Figure 2A).”
BackgroundColonic absorption of unconjugated bile acids
Mekhjian, H. S., Phillips, S. F., & Hofmann, A. F. (1979) · Digestive Diseases and Sciences · doi:10.1007/bf01489324 · Cited by 138
Zwolinska-Wcislo, M. M., Brzozowski, T., Budak, A., Kwiecień, S., Śliwowski, Z., Drozdowicz, D., Trojanowska, D., Rudnicka‐Sosin, L., Mach, T., Konturek, S. J., et al. (2009) · PubMed · Cited by 130
Farnesoid X Receptor: From Structure to Potential Clinical Applications
Pellicciari, R., Costantino, G., & Fiorucci, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0582221 · Cited by 130
Self-citationThe Pharmacology of Bile Acids and Their Receptors
Fiorucci, S., & Distrutti, E. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_238 · Cited by 124 · cited 2×
“There is growing interest in GPBAR1 pharmacology and on its immune-regulatory effects [10,14].”
BackgroundSelf-citationFarnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease
Nijmeijer, R. M., Gadaleta, R. M., van Mil, S. W. C., van Bodegraven, A. A., Crusius, J. B. A., Dijkstra, G., Hommes, D. W., de Jong, D. J., Stokkers, P. C. F., Verspaget, H. W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023745 · Cited by 119
Counter-Regulatory Role of Bile Acid Activated Receptors in Immunity and Inflammation
Fiorucci, S., Cipriani, S., Mencarelli, A., Renga, B., Distrutti, E., & Baldelli, F. (2010) · Current Molecular Medicine · doi:10.2174/1566524011009060579 · Cited by 110
Self-citationMolecular Basis of Endocrine Regulation by Orphan Nuclear Receptor Small Heterodimer Partner
CHANDA, D., PARK, J.-H., & CHOI, H.-S. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-103 · Cited by 108 · cited 1×
“The expression of atypical nuclear receptor small heterodimer partner (SHP) is generally used to confirm an FXR activation because FXR directly regulates SHP expression [47].”
BackgroundBile Acid Malabsorption in Inflammatory Bowel Disease
Vítek, L. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000193 · Cited by 99 · cited 1×
“Finally, we will provide some insights on how BARs may represent an interesting therapeutic target in the development of novel therapies for IBD [6,7].”
BackgroundDegradation of steroids by intestinal bacteria I. Deconjugation of bile salts
Aries, V. C., & Hill, M. J. (1970) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(70)90123-2 · Cited by 96
Chen, Y., Le, T. H., Du, Q., Zhao, Z., Liu, Y., Zou, J., Hua, W., Liu, C., & Zhu, Y. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.021 · Cited by 92 · cited 1×
“Activation of GPBAR1 by secondary bile acid DCA and LCA cause a GPBAR1-cAMP-PKA-dependent ubiquitination of NLRP3, thus inhibiting its activation [50,53,62].”
BackgroundCellular pathways in the development of human and murine innate lymphoid cells
Scoville, S. D., Freud, A. G., & Caligiuri, M. A. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.11.003 · Cited by 90
Splenic dendritic cell involvement in FXR-mediated amelioration of DSS colitis
Massafra, V., Ijssennagger, N., Plantinga, M., Milona, A., Pittol, J. M. R., Boes, M. L., & van Mil, S. W. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.001 · Cited by 85 · cited 2×
“The mechanisms that support these immune-modulatory activities of FXR in cells of innate immunity involve both NF-KBdependent and -independent pathways as discussed in previous paragraphs [39,55,99,100].”
BackgroundFesta, C., Renga, B., D’Amore, C., Sepe, V., Finamore, C., De Marino, S., Carino, A., Cipriani, S., Monti, M. C., Zampella, A., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501273r · Cited by 84
Self-citationPARAMETERS IN 7α‐DEHYDROXYLATION OF BILE ACIDS BY ANAEROBIC LACTOBACILLI
Midtvedt, T., & Norman, A. (1968) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1968.tb01345.x · Cited by 81
Stojancevic, M., Stankov, K., & Mikov, M. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/538452 · Cited by 75
Chenodeoxycholic Acid: An Update on Its Therapeutic Applications
Fiorucci, S., & Distrutti, E. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_226 · Cited by 75 · cited 1×
“Bile acids are the largest family of steroidal mediators found in mammalians, and as mentioned above, have been identified as the physiological ligands GPCR and nuclear receptors, mainly expressed in the entero-hepatic system and in immune cells [16,22].”
BackgroundSelf-citationBile acid studies in uncomplicated Crohn's disease.
Vantrappen, G., Ghoos, Y., Rutgeerts, P., & Janssens, J. (1977) · Gut · doi:10.1136/gut.18.9.730 · Cited by 73
Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders
Fiorucci, S., Baldoni, M., Ricci, P., Zampella, A., Distrutti, E., & Biagioli, M. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.04.008 · Cited by 73 · cited 1×
“There is growing interest in GPBAR1 pharmacology and on its immune-regulatory effects [10,14].”
BackgroundSelf-citationBiagioli, M., Carino, A., Fiorucci, C., Marchianò, S., Di Giorgio, C., Roselli, R., Magro, M., Distrutti, E., Bereshchenko, O., Scarpelli, P., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.06.003 · Cited by 67 · cited 1×
“We demonstrated in two mouse models of acute hepatitis induced by concanavalin A (Con A) orα-galactosyl-ceramide (α-GalCer), that the activation of GPBAR1 with a synthetic selective ligand alleviates the disease by counteracting the polarization of NKT towards the pro-inflammatory subgroup NKT1 while inducing bias tow…”
BackgroundSelf-citationIBD and Bile Acid Absorption: Focus on Pre-clinical and Clinical Observations
Fitzpatrick, L. R., & Jenabzadeh, P. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00564 · Cited by 62 · cited 1×
“Finally, we will provide some insights on how BARs may represent an interesting therapeutic target in the development of novel therapies for IBD [6,7].”
BackgroundChen, X., Yang, D., Shen, W., Dong, H., Wang, J. M., Oppenheim, J. J., & Howard, O. M. Z. (2000) · Inflammation Research · doi:10.1007/s000110050656 · Cited by 60 · cited 1×
“Among the membrane receptors activated by bile acids, we find the sphingosine 1-phosphate receptor (S1PR2) [30], which binds LCA, the muscarinic receptor M2 and M3, activated by DCA and LCA, the formyl peptide receptors (FPR), of which CDCA is an antagonist [31], and vascular endothelial growth factor receptor (VEGF-R…”
BackgroundSignaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity
Biagioli, M., & Carino, A. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_225 · Cited by 56 · cited 2×
“In humans, the bile acid pool consists of CA (≈40%), CDCA (≈40%), DCA (≈20%), with a glycine over taurine conjugation ratio of 3–1 [2,15,16].”
BackgroundSelf-citationAltered Fecal Bile Acid Pattern in Patients with Inflammatory Bowel Disease
Kruis, W., Kalek, H.-D., Stellaard, F., & Paumgartner, G. (1986) · Digestion · doi:10.1159/000199367 · Cited by 55
Yang, Z., Koehler, A. N., & Wang, L. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0153 · Cited by 54 · cited 1×
“[49] showed that SHP stabilizes the binding of the inhibitory complex on the promoter of the chemokine (C-C motif) ligand (CCl) 2 by inhibiting the recruitment of the NF-kB p65 subunit by decreasing the expression of this gene.”
BackgroundBassolas-Molina, H., Raymond, E. L., Labadia, M. E., Wahle, J. A., Ferrer-Picón, E., Panzenbeck, M., Zheng, J., Harcken, C., Hughes, R. O., Turner, M. S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02307 · Cited by 51 · cited 1×
“Both groups demonstrated that binding of RORγt to 3-oxo-LCA decreased IL-17 production and Th17 cell numbers by attenuating intestinal inflammation in a mouse model of colitis [72,73].”
BackgroundBiagioli, M., Carino, A., Fiorucci, C., Marchianò, S., Di Giorgio, C., Bordoni, M., Roselli, R., Baldoni, M., Distrutti, E., Zampella, A., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901427 · Cited by 48
Self-citationKinetics of primary bile acids in patients with non‐operated Crohn's disease
RUTGEERTS, P., GHOOS, Y., & VANTRAPPEN, G. (1982) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1982.tb00950.x · Cited by 45 · cited 2×
“These changes occurred only in CD with ileocolic involvement [75].”
BackgroundResultCounter-Regulatory Role of Bile Acid Activated Receptors in Immunity and Inflammation
Fiorucci, S., Cipriani, S., Mencarelli, A., Renga, B., Distrutti, E., & Baldelli, F. (2010) · Current Molecular Medicine · doi:10.2174/156652410792231312 · Cited by 45
Self-citationDe Marino, S., Carino, A., Masullo, D., Finamore, C., Marchianò, S., Cipriani, S., Di Leva, F. S., Catalanotti, B., Novellino, E., Limongelli, V., et al. (2017) · Scientific Reports · doi:10.1038/srep43290 · Cited by 44
Self-citationFXR activation inhibits inflammation and preserves the intestinal barrier in IBD
Wildenberg, M. E., & van den Brink, G. R. (2011) · Gut · doi:10.1136/gut.2010.233304 · Cited by 43
Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis
Miyazaki, T., Shirakami, Y., Mizutani, T., Maruta, A., Ideta, T., Kubota, M., Sakai, H., Ibuka, T., Genovese, S., Fiorito, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-79916-5 · Cited by 40
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa
Distrutti, E., Santucci, L., Cipriani, S., Renga, B., Schiaroli, E., Ricci, P., Donini, A., & Fiorucci, S. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1041-8 · Cited by 33 · cited 2×
“BARs widely expressed receptors and are found in different cells of the gastrointestinal tract: intestinal epithelial cells (FXR and GPBAR1), intestinal muscle and neurons (GPBAR1), biliary cells (FXR and GPBAR1), hepatocytes (FXR), liver sinusoidal cells (FXR and GPBAR1), and liver and intestinal endothelial cells (F…”
BackgroundSelf-citationSpecial FX: Harnessing the Farnesoid-X-Receptor to Control Bile Acid Synthesis
Fiorucci, S., Distrutti, E., & Biagioli, M. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06840-7 · Cited by 12 · cited 14×
“Subsequently, the enzyme 7α-dehydroxylase expressed by Clostridium and Eubacterium performs the 7α-dehydroxylation on ring B that converts CA in deoxycholic acid (DCA) and CDCA in lithocholic acid (LCA) called secondary (or degenerated) bile acids.”
BackgroundSelf-citationNatural killer T cells: Novel players in biliary disease?
Sebode, M., & Schramm, C. (2015) · Hepatology · doi:10.1002/hep.27862 · Cited by 4 · cited 1×
“In this study, we have shown that obeticholic acid (INT-747) inhibited the influx of NKT cells and the ability of these cells to produce osteopontin in rodent models of acute hepatitis [42,56,57].”
Background
Cited by
Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis
Wang, J., Zhu, N., Su, X., Gao, Y., & Yang, R. (2023) · Cells · doi:10.3390/cells12050793 · Cited by 588
Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity
Su, X., Gao, Y., & Yang, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127743 · Cited by 159
The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease
Thomas, J. P., Modos, D., Rushbrook, S. M., Powell, N., & Korcsmaros, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.829525 · Cited by 156
Bile acids and their receptors in regulation of gut health and diseases
Lin, S., Wang, S., Wang, P., Tang, C., Wang, Z., Chen, L., Luo, G., Chen, H., Liu, Y., Feng, B., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101210 · Cited by 131
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
Li, T., & Chiang, J. Y. L. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000978 · Cited by 90
Metadata
- Authors
- Biagioli, M., Marchianò, S., Carino, A., Di Giorgio, C., Santucci, L., Distrutti, E., & Fiorucci, S.
- Affiliations
- University of Perugia (IT)
- Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy
- Azienda Ospedaliera di Perugia (IT)
- Corresponding author
- Biagioli, Michele
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-05-21
- Volume
- 10
- Issue
- 6
- Pages
- 1281
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC8224328
- OpenAlex
- W3162040744
- Cited by
- 103
- References
- 108
- Citations by year
- 2026: 23 · 2025: 21 · 2024: 21 · 2023: 23 · 2022: 15
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- bile acids, bile acid receptors, inflammatory bowel disease, TGR5, farnesoid X receptor, RORγt, gut microbiota, dysbiosis, intestinal inflammation, innate lymphoid cells, Th17 cells, dendritic cells, macrophages, secondary bile acids, host-microbe communication
- MeSH terms
- Gastrointestinal Microbiome, Receptor, Farnesoid X-Activated, Animals, Bile Acids and Salts, Humans, Immunity, Innate, Inflammatory Bowel Diseases, Receptors, Cytoplasmic and Nuclear, Receptors, G-Protein-Coupled
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.